Carregant...

Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans

While SARS-CoV-2 specific neutralizing antibodies have been developed for therapeutic purposes, the specific viral triggers that drive the generation of SARS-CoV-2 specific IgG and IgM antibodies remain only partially characterized. Moreover, it is unknown whether endogenously derived antibodies dri...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Viruses
Autors principals: Yang, Shuyi, Jerome, Keith R., Greninger, Alexander L., Schiffer, Joshua T., Goyal, Ashish
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8003723/
https://ncbi.nlm.nih.gov/pubmed/33804667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13030516
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!